Regeneron Pharmaceuticals, Inc. (REGN)
Live and historical stock data for Regeneron Pharmaceuticals, Inc., delivered through Axion's financial data API - pricing, fundamentals, SEC filings, ownership, ETF exposure and sentiment in one JSON response.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also o…
GET /stocks/REGN/pricesREGN Price History
Weekly close prices for Regeneron Pharmaceuticals, Inc., pulled directly from Axion's historical market data API.
REGN Fundamentals - Financial Analytics API
Multi-year Regeneron Pharmaceuticals, Inc. financial statement data, structured for a quantitative finance API workflow - no PDF parsing or scraping required.
GET /financials/REGN/revenueRevenue & Net Income
Annual revenue vs. net income, sourced from SEC filings.
- Net Income
- Revenue
GET /financials/REGN/cashflow/freeFree Cash Flow vs. CapEx
Cash generated after operating costs vs. capital reinvested into the business.
- CapEx
- Free Cash Flow
GET /financials/REGN/epsEPS Trend (TTM)
Trailing twelve-month earnings per share, by report date.
GET /financials/REGN/roe · /deProfitability & Leverage
Return on equity vs. debt-to-equity, by report date.
- Debt/Equity
- ROE
REGN Valuation - Investment Research API
DCF fair value, analyst consensus and the 52-week trading range for REGN, built for investment research API and trading data API use cases.
GET /financials/dcf/REGN/valueMargin of safety: 0.9%
GET /profiles/REGN/summary52W Range: $521.00 - $821.11
GET /profiles/REGN/recommendationAnalyst Consensus Trend
Strong buy / buy / hold / sell counts across recent trailing periods.
- Buy
- Hold
- Sell
- Strong Buy
ETF & Fund Exposure to REGN
Every mutual fund and ETF reporting a position in REGN, searchable by fund name - a direct look at institutional financial data API coverage for this ticker.
GET /insiders/REGN/funds| Fund / ETF | Shares Held | % Held | Value |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | - | 3.2% | $2.06B |
| Dodge & Cox Funds-Dodge & Cox Stock Fund | - | 2.8% | $1.81B |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | - | 2.5% | $1.60B |
| Invesco QQQ Trust, Series 1 | - | 2.2% | $1.40B |
| iShares Trust-iShares Core S&P 500 ETF | - | 1.3% | $813.01M |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | - | 1.3% | $804.35M |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | - | 1.2% | $756.83M |
| PUTNAM LARGE CAP VALUE FUND | - | 1.1% | $712.47M |
| VANGUARD INDEX FUNDS-Vanguard Value Index Fund | - | 0.9% | $599.17M |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | - | 0.9% | $581.07M |
Companies Linked to REGN - Trading Data API
Peers, suppliers and customers mapped from Axion's supply chain API, useful for building correlated, cross-company trading data API signals.
- Tenaya Therapeutics, Inc.TNYA
- Biomea Fusion IncBMEA
- CNS Pharmaceuticals, Inc.CNSP
- NanoViricides, Inc.NNVC
- Genprex IncGNPX
- Neumora Therapeutics, Inc.NMRA
REGN Ownership - Institutional Financial Data API
Insider, institutional and public ownership breakdown, plus the latest insider transactions.
GET /insiders/REGN/ownership- Insiders
- Institutions
- Public / Other
| Insider | Activity | Shares | Value |
|---|---|---|---|
| RYAN ARTHUR F | Sale at price 701.76 - 714.13 per share. | 100 | $70.5K |
| RYAN ARTHUR F | Sale at price 771.32 - 779.71 per share. | 100 | $77.7K |
| RYAN ARTHUR F | Sale at price 777.46 - 789.28 per share. | 100 | $78.5K |
| ZOGHBI HUDA Y | Sale at price 774.68 - 790.00 per share. | 1.6K | $1.28M |
| ZOGHBI HUDA Y | Conversion of Exercise of derivative security at price 376.69 per share. | 1.6K | $617.0K |
REGN ESG Scores
Environmental, social, governance and controversy scores, pulled from the same financial data API.
GET /esg/REGNESG Score Breakdown
GET /filings/REGNRecent SEC Filings
- 4Aug 12, 2026
- 4Aug 12, 2026
- 144Aug 10, 2026
- 144Aug 10, 2026
- 13F-HRAug 7, 2026
GET /news/REGNLatest News
- REGN DEADLINE: Levi & Korsinsky Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire Wed, 12 Aug 2026 14:09:00 GMT
- Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - marketwatch.com Thu, 13 Aug 2026 20:43:00 GMT
- Bernstein Adjusts PT on Regeneron Pharmaceuticals to $756 From $753, Maintains Market Perform Rating - marketscreener.com Fri, 14 Aug 2026 10:15:59 GMT
- Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - WBOC TV Wed, 12 Aug 2026 16:00:00 GMT
- REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Morningstar Tue, 11 Aug 2026 15:30:00 GMT
See It In Action - API & Python Example
The same request that powers this page, in cURL, Python and JavaScript, plus an example chart rendered straight from the response.
curl https://api.axionquant.com/stocks/REGN/quote \
-H "Authorization: Bearer YOUR_API_KEY"GET /financials/REGN/revenueRendered from the response above
Revenue vs. net income - the exact data returned by the Python example.
- Historical prices (OHLCV)
- Financial statements & ratios
- DCF valuation & analyst consensus
- Insider & institutional ownership
- ETF & fund exposure
- ESG scores
- Supply chain & peers
- SEC filings
- News, social & analyst sentiment
- Company news
Why Developers Use Axion's Financial Data API
A single stock market API and market data API for pricing, fundamentals and alternative data - built for quant research API and institutional financial data API workflows.
One API, every asset class
Equities, ETFs, crypto, forex and futures through a single financial data API - no juggling vendors.
Institutional-grade fundamentals
Point-in-time financial statements sourced from SEC filings, built for an institutional financial data API workflow.
Built for backtesting
Daily and weekly historical market data going back years, ready for a quantitative finance API pipeline.
Alternative data included
ESG, sentiment, supply chain and insider activity - a financial intelligence API that goes beyond price.
Free tier, real docs
Explore the stock data API for free - grab a key and start pulling market data in minutes.
Research You Can Build on REGN
Starting points for quant research API and investment research API projects using this ticker.
Backtest a strategy on REGN
Pull REGN's full daily price history and combine it with fundamentals to backtest momentum or mean-reversion signals.
Build a DCF valuation model
Feed live revenue, free cash flow and discount-rate inputs into your own model, benchmarked against Axion's DCF fair value.
Screen for Health Technology peers
Use supply-chain and sector classification data to build a comparable-company screen around REGN.
Factor in ESG and sentiment
Combine ESG scores with news and social sentiment to test alternative-data factors against returns.
Track insider conviction
Monitor insider buying and selling activity, plus ETF and institutional ownership shifts, ahead of catalysts.
Map supply-chain risk
Trace REGN's suppliers and customers to model second-order exposure to sector shocks.
Explore More From Axion
One account, every dataset - browse the rest of Axion's market data API and alternative data catalog.
Built for Teams Like These
From independent researchers to institutional desks - Axion powers financial applications at every scale.
REGN Data, Built for Developers and Quant Teams
Regeneron Pharmaceuticals, Inc. pricing, fundamentals and alternative data are available through Axion's financial data API - a single, consistent stock data API and market data API covering equities, ETFs, crypto, forex and futures. Instead of stitching together a stock market API for pricing, a separate SEC filings feed, and a spreadsheet for fundamentals, pull REGN's revenue, EPS, insider activity, ETF exposure, ESG scores and DCF valuation from one financial analytics API.
Axion is built for institutional financial data API and quant research API workflows: point-in-time financial statements for backtesting, a historical market data API with daily and weekly granularity going back years, and an investment research API layer that surfaces analyst consensus, sentiment and ownership changes for REGN alongside every other ticker you track. Whether you're building a quantitative finance API pipeline, a trading data API for a systematic strategy, or a research dashboard, REGN's complete dataset is one authenticated request away.
Frequently asked questions
Does Axion offer a stock market API for REGN?
Yes. Axion's stock data API returns real-time quotes, historical prices, fundamentals, SEC filings, ownership and sentiment for REGN through a single financial data API key.
Can I pull REGN's historical market data programmatically?
Yes - the historical market data API returns daily, weekly, monthly, quarterly or yearly OHLCV bars for REGN, with no fixed lookback limit.
Is REGN's fundamental data suitable for quant research?
Yes. Revenue, net income, free cash flow, ROE and DCF valuation are exposed as structured JSON, ready for a quantitative finance API or quant research API pipeline - no scraping or PDF parsing required.
Can I see which ETFs and funds hold REGN?
Yes. Axion's institutional financial data API includes fund and ETF ownership, insider transactions and major-holder breakdowns for REGN, refreshed alongside SEC filings.